Shell Asset Management’s AbbVie ABBV Stock Holding History

Shell Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.16M	Sell	22,295 -28,785	-56%	-$5.86M	0.52%	21
2025 Q2	$9.48M	Buy	51,080 +15,438	+43%	+$2.87M	0.33%	50
2025 Q1	$7.47M	Sell	35,642 -1,068	-3%	-$208K	0.35%	47
2024 Q4	$6.52M	Buy	36,710 +167	+0.5%	+$30.7K	0.29%	57
2024 Q3	$7.22M	Buy	+36,543	New	+$6.82M	0.32%	58
2024 Q1	$6.45M	Sell	37,616 -1,985	-5%	-$342K	0.29%	62
2023 Q4	$6.14M	Sell	39,601 -9,507	-19%	-$1.39M	0.28%	66
2023 Q3	$7.32M	Sell	49,108 -1,779	-3%	-$261K	0.3%	59
2023 Q2	$6.86M	Sell	50,887 -17,129	-25%	-$2.51M	0.27%	66
2023 Q1	$10.8M	Sell	68,016 -486	-0.7%	-$74.3K	0.45%	42
2022 Q4	$11.1M	Sell	68,502 -16,119	-19%	-$2.47M	0.48%	41
2022 Q3	$11.4M	Sell	84,621 -21,484	-20%	-$3.08M	0.44%	40
2022 Q2	$16.3M	Sell	106,105 -18,543	-15%	-$2.83M	0.48%	37
2022 Q1	$20.2M	Sell	124,648 -6,514	-5%	-$946K	0.48%	32
2021 Q4	$17.8M	Sell	131,162 -11,941	-8%	-$1.41M	0.36%	49
2021 Q3	$15.4M	Sell	143,103 -16,805	-11%	-$1.92M	0.35%	54
2021 Q2	$18M	Sell	159,908 -58,179	-27%	-$6.55M	0.35%	56
2021 Q1	$23.6M	Buy	218,087 +10,663	+5%	+$1.14M	0.47%	36
2020 Q4	$22.2M	Sell	207,424 -10,961	-5%	-$1.05M	0.46%	33
2020 Q3	$19.1M	Sell	218,385 -7,647	-3%	-$720K	0.44%	38
2020 Q2	$22.2M	Sell	226,032 -10,140	-4%	-$893K	0.55%	28
2020 Q1	$18M	Sell	236,172 -2,429	-1%	-$207K	0.5%	34
2019 Q4	$21.1M	Buy	238,601 +4,255	+2%	+$353K	0.46%	39
2019 Q3	$17.7M	Sell	234,346 -4,239	-2%	-$291K	0.41%	52
2019 Q2	$17.4M	Buy	238,585 +10,421	+5%	+$819K	0.38%	53
2019 Q1	$18.4M	Buy	228,164 +2,122	+0.9%	+$174K	0.41%	49
2018 Q4	$20.8M	Buy	226,042 +9,176	+4%	+$807K	0.52%	37
2018 Q3	$20.5M	Sell	216,866 -18,400	-8%	-$1.74M	0.4%	52
2018 Q2	$21.8M	Buy	235,266 +8,827	+4%	+$862K	0.45%	41
2018 Q1	$21.4M	Sell	226,439 -2,355	-1%	-$259K	0.43%	49
2017 Q4	$22.1M	Buy	228,794 +40,287	+21%	+$3.8M	0.44%	50
2017 Q3	$16.8M	Sell	188,507 -1,283	-0.7%	-$97.7K	0.37%	63
2017 Q2	$13.8M	Buy	189,790 +20,401	+12%	+$1.37M	0.29%	94
2017 Q1	$11M	Sell	169,389 -24,252	-13%	-$1.52M	0.24%	117
2016 Q4	$12.1M	Buy	193,641 +19,726	+11%	+$1.2M	0.28%	91
2016 Q3	$11M	Buy	173,915 +6,923	+4%	+$448K	0.23%	124
2016 Q2	$10.3M	Buy	166,992 +34,604	+26%	+$2.11M	0.24%	108
2016 Q1	$7.56M	Sell	132,388 -784	-0.6%	-$43.7K	0.18%	141
2015 Q4	$7.89M	Sell	133,172 -170,603	-56%	-$9.83M	0.19%	127
2015 Q3	$17.5M	Buy	303,775 +122,648	+68%	+$7.98M	0.28%	77
2015 Q2	$12.2M	Sell	181,127 -77,276	-30%	-$5.04M	0.24%	100
2015 Q1	$15.1M	Sell	258,403 -79,476	-24%	-$4.8M	0.26%	101
2014 Q4	$22.1M	Buy	337,879 +34,104	+11%	+$2.15M	0.35%	61
2014 Q3	$17.5M	Sell	303,775 -4,844	-2%	-$269K	0.27%	78
2014 Q2	$17.4M	Buy	308,619 +35,013	+13%	+$1.84M	0.27%	82
2014 Q1	$14.1M	Buy	273,606 +4,695	+2%	+$237K	0.23%	89
2013 Q4	$14.2M	Sell	268,911 -157,106	-37%	-$7.72M	0.24%	85
2013 Q3	$19.1M	Sell	426,017 -7,969	-2%	-$353K	0.35%	58
2013 Q2	$17.9M	Buy	+433,986	New	+$19M	0.34%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shell Asset Management's ABBV Position: Q3 2025 in Review

Shell Asset Management reduced its AbbVie (ABBV) stake by 56% in Q3 2025, selling an estimated $5.86M and leaving 22,295 shares worth $5.16M. The position accounts for 0.52% of the portfolio, ranked #21.

Shell Asset Management first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $23.6M in Q1 2021. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Shell Asset Management held 22,295 shares of AbbVie worth $5.16M as of Q3 2025.
Shell Asset Management sold 28,785 AbbVie shares in Q3 2025, an estimated $5.86M.
AbbVie made up 0.52% of Shell Asset Management's portfolio in Q3 2025, its #21 holding.
Shell Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
Shell Asset Management's AbbVie position peaked at $23.6M in Q1 2021.
3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.